Atlas Trials

Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section

Clinical trial NCT06681805 · COMPLETED

Trial details

NCT number
NCT06681805
Sponsor
Kafrelsheikh University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
ProphylacticMirtazapineIntrathecalMorphineNauseaVomiting
Start date
2023-01-01
Primary completion
2024-09-25
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.